Here's what happened, and why it's bullish for Lilly's stock.

Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...

Cheesecake Factory gains after report activist pushing for breakup. Lilly sues companies selling compounded Zepbound, ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Me CEO Anne Wojcicki continues to maintain a strong outlook despite recent high-profile stumbles. “We are a long-term company ...

Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

Fintel reports that on October 21, 2024, EF Hutton initiated coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a Buy ...

The global GLP-1 receptor agonist market is poised for extraordinary expansion, driven by an increase in therapeutic applications and favorable market projections. Recent analysis indicates a ...

Northwestern Medicine surgeons say, head to head, bariatric surgery is more cost effective for patients, employers and ...

Have you finally decided to explore treatment plans for weight loss or erectile dysfunction? Are you finding that ...